ZENTEK LTD (ZTEK) Stock Fundamental Analysis

NASDAQ:ZTEK • CA98942X1024

0.642 USD
-0.01 (-1.61%)
Last: Feb 13, 2026, 08:00 PM
Fundamental Rating

2

Overall ZTEK gets a fundamental rating of 2 out of 10. We evaluated ZTEK against 185 industry peers in the Health Care Equipment & Supplies industry. ZTEK has a bad profitability rating. Also its financial health evaluation is rather negative. ZTEK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ZTEK had negative earnings in the past year.
  • ZTEK had a negative operating cash flow in the past year.
  • In the past 5 years ZTEK always reported negative net income.
  • In the past 5 years ZTEK always reported negative operating cash flow.
ZTEK Yearly Net Income VS EBIT VS OCF VS FCFZTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • ZTEK's Return On Assets of -48.58% is on the low side compared to the rest of the industry. ZTEK is outperformed by 66.13% of its industry peers.
  • ZTEK's Return On Equity of -70.13% is in line compared to the rest of the industry. ZTEK outperforms 44.62% of its industry peers.
Industry RankSector Rank
ROA -48.58%
ROE -70.13%
ROIC N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ZTEK Yearly ROA, ROE, ROICZTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

  • ZTEK has a Gross Margin (48.67%) which is in line with its industry peers.
  • ZTEK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZTEK Yearly Profit, Operating, Gross MarginsZTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

2

2. Health

2.1 Basic Checks

  • ZTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ZTEK has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ZTEK has been increased compared to 5 years ago.
  • ZTEK has a better debt/assets ratio than last year.
ZTEK Yearly Shares OutstandingZTEK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ZTEK Yearly Total Debt VS Total AssetsZTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 1.90 indicates that ZTEK is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ZTEK has a Altman-Z score of 1.90. This is in the better half of the industry: ZTEK outperforms 62.37% of its industry peers.
  • A Debt/Equity ratio of 0.15 indicates that ZTEK is not too dependend on debt financing.
  • ZTEK has a Debt to Equity ratio of 0.15. This is in the better half of the industry: ZTEK outperforms 60.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.9
ROIC/WACCN/A
WACC9.03%
ZTEK Yearly LT Debt VS Equity VS FCFZTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M 40M

2.3 Liquidity

  • ZTEK has a Current Ratio of 0.79. This is a bad value and indicates that ZTEK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.79, ZTEK is doing worse than 90.32% of the companies in the same industry.
  • A Quick Ratio of 0.53 indicates that ZTEK may have some problems paying its short term obligations.
  • ZTEK's Quick ratio of 0.53 is on the low side compared to the rest of the industry. ZTEK is outperformed by 90.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.53
ZTEK Yearly Current Assets VS Current LiabilitesZTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.08% over the past year.
  • Looking at the last year, ZTEK shows a very strong growth in Revenue. The Revenue has grown by 2223.10%.
  • Measured over the past years, ZTEK shows a very strong growth in Revenue. The Revenue has been growing by 35.95% on average per year.
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZTEK Yearly Revenue VS EstimatesZTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 5M 10M
ZTEK Yearly EPS VS EstimatesZTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2023 2024 -0.05 -0.1 -0.15

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZTEK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZTEK Price Earnings VS Forward Price EarningsZTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZTEK Per share dataZTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • ZTEK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ZENTEK LTD

NASDAQ:ZTEK (2/13/2026, 8:00:02 PM)

0.642

-0.01 (-1.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)06-24
Inst Owners1.71%
Inst Owner Change-41.25%
Ins Owners0.78%
Ins Owner ChangeN/A
Market Cap69.03M
Revenue(TTM)915.30K
Net Income(TTM)-8.20M
Analysts84.44
Price TargetN/A
Short Float %0.05%
Short Ratio0.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 102.75
P/FCF N/A
P/OCF N/A
P/B 8.05
P/tB 8.05
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.01
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.58%
ROE -70.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.67%
FCFM N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 88.48%
Cap/Sales 54.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.53
Altman-Z 1.9
F-Score4
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)182.79%
Cap/Depr(5y)454.82%
Cap/Sales(3y)1708.52%
Cap/Sales(5y)12638%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.4%
OCF growth 3YN/A
OCF growth 5YN/A

ZENTEK LTD / ZTEK FAQ

Can you provide the ChartMill fundamental rating for ZENTEK LTD?

ChartMill assigns a fundamental rating of 2 / 10 to ZTEK.


Can you provide the valuation status for ZENTEK LTD?

ChartMill assigns a valuation rating of 0 / 10 to ZENTEK LTD (ZTEK). This can be considered as Overvalued.


Can you provide the profitability details for ZENTEK LTD?

ZENTEK LTD (ZTEK) has a profitability rating of 1 / 10.


How financially healthy is ZENTEK LTD?

The financial health rating of ZENTEK LTD (ZTEK) is 2 / 10.